0001209191-19-021625.txt : 20190328
0001209191-19-021625.hdr.sgml : 20190328
20190328162128
ACCESSION NUMBER: 0001209191-19-021625
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190327
FILED AS OF DATE: 20190328
DATE AS OF CHANGE: 20190328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: King Rachel K.
CENTRAL INDEX KEY: 0001589712
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 19712254
MAIL ADDRESS:
STREET 1: C/O GLYCOMIMETICS, INC.
STREET 2: 401 PROFESSIONAL DRIVE, SUITE 250
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-27
0
0001000694
NOVAVAX INC
NVAX
0001589712
King Rachel K.
C/O NOVAVAX, INC.
20 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
1
0
0
0
Common Stock
2019-03-27
4
P
0
42000
0.5298
A
42000
D
Common Stock
2019-03-27
4
P
0
22000
0.5298
A
22000
I
See Footnote
Common Stock
2019-03-27
4
P
0
22000
0.5298
A
22000
I
See Footnote
Represents shares attributable to the Reporting Person as indirect holdings held in a trust for the benefit of the Reporting Person's child.
Represents shares attributable to the Reporting Person as indirect holdings held in a trust for the benefit of the Reporting Person's child.
/s/ John A. Herrmann III, Attorney-in-Fact
2019-03-28